{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q10589",
      "entity_text" : "BST-2",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-1006" ],
      "Cellular_component" : [ "go:GO:0005886" ],
      "CellType" : [ "cl:CL:0000784" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Previous studies showed that tetherin / BST-2 is constitutively expressed in terminally differentiated B cells, bone marrow stromal cells, and plasmacytoid dendritic cells, and is also broadly induced by treatment with type I IFN in various cell types.",
  "reading_complete" : "2020-08-08T10:39:31Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T10:38:39Z",
  "trigger" : "expressed",
  "evidence" : [ "BST-2 is constitutively expressed" ],
  "pmc_id" : "3316994",
  "score" : 0
}